Peptide of the Week: GLOW and KLOW — 10% Off This Week
Peptide of the Week: GLOW and KLOW — 10% Off This Week
Research Comparison Guide for Canada (2025–2026)
Melanotan peptides are frequently discussed in scientific literature in relation to the melanocortin receptor (MCR) system, which plays a role in pigmentation signaling and broader neuroendocrine pathways. Among these peptides, Melanotan 1 (MT1) and Melanotan 2 (MT2) are often compared due to structural similarities but meaningful differences in receptor activity and research focus.
This guide provides a research-focused comparison of MT1 and MT2 to help Canadian researchers understand how these peptides differ in structure, receptor interactions, and experimental relevance.
The melanocortin system consists of several receptors (MC1R–MC5R), each associated with different biological signaling pathways. Research into melanocortin peptides aims to better understand how receptor selectivity and agonist profiles influence downstream effects in controlled models.
Primary scientific references:
Melanocortin receptor biology overview — Nature Reviews Endocrinology
https://www.nature.com/articles/nrendo.2010.75
Melanocortin signaling pathways — Endocrine Reviews
https://academic.oup.com/edrv/article/23/6/710/2355153
Melanotan 1 (MT1), sometimes referenced in the literature alongside afamelanotide-related compounds, is a synthetic melanocortin peptide studied primarily for MC1R (melanocortin-1 receptor) interaction.
Greater selectivity toward MC1R
Often discussed in pigmentation-related research models
Lower reported cross-activity at other melanocortin receptors compared to MT2
Scientific context:
MC1R signaling and pigmentation research — Journal of Investigative Dermatology
https://www.sciencedirect.com/science/article/pii/S0022202X15529526
Melanotan 2 (MT2) is a synthetic melanocortin peptide studied for broader receptor activity across multiple melanocortin receptors, including MC1R, MC3R, and MC4R.
Broader melanocortin receptor engagement
Frequently discussed in melanocortin pathway and neuroendocrine research
More commonly referenced in comparative and mechanistic studies
Scientific context:
Melanocortin agonist receptor activity — Cell Metabolism
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(08)00142-3
| Feature | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| Receptor focus | Primarily MC1R | MC1R, MC3R, MC4R |
| Research emphasis | Pigmentation signaling | Broader melanocortin pathways |
| Receptor selectivity | More selective | Less selective (multi-receptor) |
| Literature volume | More narrow | Broader research interest |
These differences explain why MT2 is more frequently cited in multi-pathway melanocortin research, while MT1 is typically discussed in more targeted receptor studies.
Comparative research helps scientists:
Evaluate receptor selectivity vs broad activation
Study signaling differences within the melanocortin system
Understand how peptide structure influences receptor binding
Comparison does not imply superiority of one compound over another; it reflects different experimental applications.
Neither MT1 nor MT2 is approved as a therapeutic product in Canada. Any reference or availability is strictly within a laboratory research framework.
For regulatory context:
Research Use Regulations (Canada)
https://luxaralabs.com/research-use-regulations-canada/
Public health warnings often relate to unregulated consumer products, not controlled research materials — reinforcing the importance of documentation, purity, and transparency in legitimate research sourcing.
Canadian researchers evaluating melanocortin peptides typically consider:
≥99% purity preferred
Third-party COAs with clear analytical methods
Helpful references:
Peptide Purity Standards (Canada)
https://luxaralabs.com/peptide-purity-standards-canada/
How to Read a COA
https://luxaralabs.com/how-to-read-a-coa/
Lab Results & COAs
https://luxaralabs.com/lab-results/
Protection from light, heat, and moisture
Appropriate shipping and storage conditions
Reference:
Peptide Storage & Handling Stability
https://luxaralabs.com/peptide-storage-handling-stability/
Faster transit
No customs delays
Improved consistency
Reference:
Peptide Shipping Guide (Canada)
https://luxaralabs.com/peptide-shipping-canada/
Melanotan 2 (MT2) Research Guide
https://luxaralabs.com/melanotan-2-canada/
PT-141 (Bremelanotide) Research Guide
https://luxaralabs.com/pt141-canada/
Peptides in Canada — Knowledge Hub
https://luxaralabs.com/peptides-canada-knowledge-hub/
Where to Buy Peptides in Canada
https://luxaralabs.com/where-to-buy-peptides-in-canada/
Retatrutide vs Tirzepatide — Research Comparison
https://luxaralabs.com/retatrutide-vs-tirzepatide/
BPC-157 vs TB-500 — Research Comparison
https://luxaralabs.com/bpc157-vs-tb500/
Peptides in the United States
https://luxaralabs.com/peptides-usa/
An overview for US-based researchers explaining how research peptides are sourced from Canada, including documentation standards, quality verification, and cross-border considerations.
US Peptide Research Regulations
https://luxaralabs.com/peptide-research-regulations-usa/
A clear explanation of how research peptides are treated under US regulatory frameworks, including FDA oversight, import screening, labeling requirements, and compliance considerations.
Shipping Peptides to the USA
https://luxaralabs.com/shipping-peptides-to-usa/
A transparent guide outlining what US researchers can expect when shipping peptides from Canada, including customs review, delivery timelines, and potential shipment outcomes.
All content provided is intended solely for scientific and educational purposes. Luxara Labs does not provide medical advice and does not market products for human or veterinary use. Any compounds referenced are designated for research use only.
The defining difference is Blood-Brain Barrier (BBB) permeability. Melanotan 1 (Afamelanotide) is a linear peptide with poor BBB permeability, making its effects primarily peripheral (skin pigmentation and photoprotection). Melanotan 2, however, is a cyclic lactam analogue that readily crosses the BBB. This allows researchers to study its central effects on the MC3R and MC4R receptors, which influence appetite, sexual behavior, and metabolic rate.
Both are non-selective agonists of the MC1, MC3, MC4, and MC5 receptors, but they trigger different experimental outcomes. MT1 is investigated primarily for its high-affinity binding to MC1R in melanocytes to study eumelanin synthesis. MT2 is utilized in studies focused on MC3R/MC4R signaling pathways to explore appetite suppression, energy homeostasis, and penile erection mechanisms.
MT1 ([Nle4, D-Phe7]--MSH) is a linear peptide designed to be more resistant to enzymatic degradation than natural -MSH. MT2 is a truncated, lactam-cyclized analogue. This cyclic structure provides even greater stability and a longer half-life in laboratory models. For long-term preservation, both lyophilized powders must be stored at -20°C and protected from light to prevent molecular fragmentation.
Because MT2 crosses the BBB and activates central receptors, laboratory models often exhibit more complex secondary responses. These include central nervous system (CNS) effects such as nausea, yawning, and increased libido. MT1’s peripheral focus results in a narrower profile, typically limited to transient facial flushing and localized skin darkening, making it a “cleaner” model for isolated photoprotection studies.
High-precision metabolic and pigmentation research depends on the absence of synthesis byproducts that could cause paradoxical immune responses. Luxara Labs ensures that every batch of MT1 and MT2 undergoes 3rd-party HPLC and MS testing to verify 99% purity. We provide expedited, temperature-stable shipping across Canada and the USA to ensure that whether you are studying peripheral phototoxicity or central metabolic pathways, your research materials arrive with their molecular integrity fully intact.
Join our list and get an instant 10% discount code — valid for first-time buyers.
